These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 14711795

  • 1. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.
    Lee TA, Weiss KB.
    Am J Respir Crit Care Med; 2004 Apr 01; 169(7):855-9. PubMed ID: 14711795
    [Abstract] [Full Text] [Related]

  • 2. Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of nonvertebral fractures among patients with COPD in the UK General Practice Research Database.
    Miller DP, Watkins SE, Sampson T, Davis KJ.
    Phys Sportsmed; 2010 Dec 01; 38(4):19-27. PubMed ID: 21150138
    [Abstract] [Full Text] [Related]

  • 3. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb 01; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 4. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M, Smith CJ, Hubbard RB.
    QJM; 2007 Aug 01; 100(8):509-17. PubMed ID: 17609226
    [Abstract] [Full Text] [Related]

  • 5. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP.
    Curr Med Res Opin; 2012 Dec 01; 28(12):1959-67. PubMed ID: 23098081
    [Abstract] [Full Text] [Related]

  • 6. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 01; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA, Fabbri LM, Davis KJ, Soriano JB.
    Respir Med; 2009 Jan 01; 103(1):85-90. PubMed ID: 18793832
    [Abstract] [Full Text] [Related]

  • 8. The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease.
    Johannes CB, Schneider GA, Dube TJ, Alfredson TD, Davis KJ, Walker AM.
    Chest; 2005 Jan 01; 127(1):89-97. PubMed ID: 15653967
    [Abstract] [Full Text] [Related]

  • 9. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 10. Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis.
    Flynn RW, MacDonald TM, Hapca A, MacKenzie IS, Schembri S.
    Respir Res; 2014 Nov 19; 15(1):141. PubMed ID: 25407604
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: A propensity score matched study.
    Tsai CH, Liao LY, Lin CL, Chung WS.
    Clin Respir J; 2018 May 19; 12(5):1830-1837. PubMed ID: 29148205
    [Abstract] [Full Text] [Related]

  • 12. Use of inhaled corticosteroids and the risk of tuberculosis.
    Lee CH, Kim K, Hyun MK, Jang EJ, Lee NR, Yim JJ.
    Thorax; 2013 Dec 19; 68(12):1105-13. PubMed ID: 23749841
    [Abstract] [Full Text] [Related]

  • 13. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study.
    Eurich DT, Lee C, Marrie TJ, Majumdar SR.
    Clin Infect Dis; 2013 Oct 19; 57(8):1138-44. PubMed ID: 23872948
    [Abstract] [Full Text] [Related]

  • 14. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
    Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW.
    Thorax; 2013 Mar 19; 68(3):256-62. PubMed ID: 22781123
    [Abstract] [Full Text] [Related]

  • 15. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD.
    Huiart L, Ernst P, Ranouil X, Suissa S.
    Eur Respir J; 2005 Apr 19; 25(4):634-9. PubMed ID: 15802336
    [Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P, Gonzalez AV, Brassard P, Suissa S.
    Am J Respir Crit Care Med; 2007 Jul 15; 176(2):162-6. PubMed ID: 17400730
    [Abstract] [Full Text] [Related]

  • 17. Effects of long-term inhaled corticosteroid treatment on fragility fractures in older women: the Manitoba BMD registry study.
    Ng BC, Leslie WD, Johnson KM, FitzGerald JM, Sadatsafavi M, Chen W.
    Osteoporos Int; 2020 Jun 15; 31(6):1155-1162. PubMed ID: 32123939
    [Abstract] [Full Text] [Related]

  • 18. Inhaled corticosteroids in COPD and the risk of lung cancer.
    Lee YM, Kim SJ, Lee JH, Ha E.
    Int J Cancer; 2018 Nov 01; 143(9):2311-2318. PubMed ID: 29943812
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroid use and risks of lung cancer and laryngeal cancer.
    Lee CH, Hyun MK, Jang EJ, Lee NR, Kim K, Yim JJ.
    Respir Med; 2013 Aug 01; 107(8):1222-33. PubMed ID: 23768737
    [Abstract] [Full Text] [Related]

  • 20. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
    Chen S, Plauschinat CA, Wu N, Fraser K, Boulanger L.
    J Med Econ; 2011 Aug 01; 14(4):458-62. PubMed ID: 21651427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.